$SGEN Seagen Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Seagen Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Seagen Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| 14159 Capital (GP, LLC | Director | 12,637 | 768,203 | Apr 01 2005 | |||
| 14159 capital (GP), LLC | Director | 323,148 | 19,644,167 | Sep 08 2011 | |||
| 14159 capital (GP), LLC | Director | 94,309 | 5,733,044 | Aug 15 2006 | |||
| 14159 capital (GP), LLC | Director | 19,561 | 1,189,113 | May 06 2005 | |||
| 14159 capital (GP), LLC | Director | 95,159 | 5,784,716 | Aug 16 2006 | |||
| 14159 capital (GP), LLC | Director | 37,791 | 2,297,315 | May 25 2006 | |||
| 14159 capital (GP), LLC | Director | 73,363 | 4,459,737 | Jun 21 2006 | |||
| 14159 capital (GP), LLC | Director | 76,660 | 4,660,161 | Jun 27 2006 | |||
| 14159 capital (GP), LLC | Director | 303,449 | 18,446,665 | Feb 04 2011 | |||
| AKKARAJU SRINIVAS | Director | 41,503 | 2,522,967 | May 19 2020 | |||
| AKKARAJU SRINIVAS | Director | 600,559 | 36,507,982 | Sep 23 2008 | |||
| AKKARAJU SRINIVAS | Director | 0 | 0 | May 30 2007 | |||
| AKKARAJU SRINIVAS | Director | 10,405 | 632,520 | Aug 20 2009 | |||
| AKKARAJU SRINIVAS | Director | 17,405 | 1,058,050 | May 20 2014 | |||
| AKKARAJU SRINIVAS | Director | 0 | 0 | May 19 2004 | |||
| AKKARAJU SRINIVAS | Director | 0 | 0 | Jan 04 2005 | |||
| Baker Biotech Capital (GP), LLC | Director | 4,966,001 | 301,883,201 | Jan 04 2012 | |||
| BAKER BIOTECH CAPITAL GP LLC | Director | 292,003 | 17,750,862 | Apr 01 2005 | |||
| Baker Biotech Capital (GP), LLC | Director | 388,638 | 23,625,304 | May 06 2005 | |||
| Baker Biotech Capital (GP), LLC | Director | 1,535,999 | 93,373,379 | Aug 16 2006 | |||
| Baker Biotech Capital (GP), LLC | Director | 667,288 | 40,564,438 | May 25 2006 | |||
| Baker Biotech Capital (GP), LLC | Director | 4,626,213 | 281,227,488 | May 04 2010 | |||
| BAKER BIOTECH CAPITAL II GP LLC | Director | 264,773 | 16,095,551 | Apr 01 2005 | |||
| Baker Biotech Capital II (GP), LLC | Director | 353,150 | 21,467,989 | May 06 2005 | |||
| Baker Biotech Capital II (Z) (GP), LLC | Director | 49,807 | 3,027,768 | May 06 2005 | |||
| Baker Biotech Capital II (Z) (GP), LLC | Director | 48,859 | 2,970,139 | May 04 2005 | |||
| Baker Biotech Capital III (GP), LLC | Director | 234,861 | 14,277,200 | May 06 2005 | |||
| Baker Biotech Capital III (GP), LLC | Director | 228,556 | 13,893,919 | May 04 2005 | |||
| Baker Biotech Capital III (Z) (GP), LLC | Director | 45,090 | 2,741,021 | May 06 2005 | |||
| Baker Biotech Capital III (Z) (GP), LLC | Director | 43,868 | 2,666,736 | May 04 2005 | |||
| BAKER BROS ADVISORS LLC | Director | 4,082,851 | 248,196,512 | May 19 2020 | |||
| BAKER BROS CAPITAL GP LLC | Director | 57,673 | 3,505,942 | Apr 01 2005 | |||
| Baker Bros. Capital (GP), LLC | Director | 76,887 | 4,673,961 | May 06 2005 | |||
| Baker Bros. Capital (GP), LLC | Director | 481,890 | 29,294,093 | May 04 2010 | |||
| Baker Bros. Capital (GP), LLC | Director | 539,130 | 32,773,713 | Jan 04 2012 | |||
| Baker Brothers Life Sciences Capital (GP), LLC | Director | 4,149,611 | 252,254,853 | Aug 16 2006 | |||
| Baker Brothers Life Sciences Capital (GP), LLC | Director | 1,515,043 | 92,099,464 | May 25 2006 | |||
| Baker Brothers Life Sciences Capital (GP), LLC | Director | 13,470,692 | 818,883,367 | Feb 04 2011 | |||
| Baker Brothers Life Sciences Capital (GP), LLC | Director | 15,131,223 | 919,827,046 | Jan 04 2012 | |||
| BAKER FELIX | Director | 4,842,742 | 294,390,286 | Nov 09 2016 | |||
| BAKER FELIX | Director | 23,993,144 | 1,458,543,224 | Dec 17 2014 | |||
| BAKER FELIX | Director | 0 | 0 | May 23 2006 | |||
| BAKER FELIX | Director | 0 | 0 | May 25 2010 | |||
| BAKER TISCH CAPITAL GP LLC | Director | 17,845 | 1,084,798 | Apr 01 2005 | |||
| Baker / Tisch Capital (GP), LLC | Director | 26,933 | 1,637,257 | May 10 2005 | |||
| Baker / Tisch Capital (GP), LLC | Director | 400,898 | 24,370,589 | May 20 2009 | |||
| Baker / Tisch Capital (GP), LLC | Director | 450,461 | 27,383,524 | Jan 04 2012 | |||
| BERGER FRANKLIN M | Director | 204,720 | 12,444,929 | Feb 25 2014 | |||
| BERGER FRANKLIN M | Director | 151,720 | 9,223,059 | Aug 25 2010 | |||
| BOERNER CHRISTOPHER S. | Executive Vice President, Comm | 72,358 | 4,398,643 | Aug 27 2014 | |||
| CARROLL TIM | CFO | 62,861 | 3,821,320 | May 05 2005 | |||
| Cline Darren S | EVP, Commercial | 72,556 | 4,410,679 | Nov 30 2018 | |||
| DANSEY ROGER D | Chief Medical Officer | 84,435 | 5,132,804 | Jun 21 2021 | |||
| DELPHI MANAGEMENT PARTNERS VI LLC | 10% Owner | 2,000,000 | 121,580,000 | Jan 19 2007 | |||
| DOBMEIER ERIC | Chief Operating Officer | 121,153 | 7,364,891 | Dec 06 2017 | |||
| DRACHMAN JONATHAN G | CMO & EVP, R & D | 178,134 | 10,828,766 | Mar 22 2018 | |||
| FELL H PERRY | Chairman | 1,294,000 | 78,662,260 | Dec 02 2003 | |||
| GALLEN JONATHAN | 10% Owner | 5,132,750 | 312,019,873 | Feb 08 2007 | |||
| GRYSKA DAVID W | Director | 46,250 | 2,811,538 | May 18 2021 | |||
| GRYSKA DAVID W | Director | 25,250 | 1,534,948 | May 20 2014 | |||
| H&Q Holdings, Inc. | 10% Owner | 27,004 | 1,641,573 | May 15 2008 | |||
| H&Q Holdings, Inc. | 10% Owner | 25,052 | 1,522,911 | Jul 29 2008 | |||
| HELLSTROM KARL ERIK | Director | 700,000 | 42,553,000 | May 18 2004 | |||
| HIMES VAUGHN B | Chief Technical Officer | 141,889 | 8,625,432 | Mar 04 2021 | |||
| HIMES VAUGHN B | EVP, Tech. Ops. & Proc. Sci. | 67,209 | 4,085,635 | Nov 14 2014 | |||
| Hoth Daniel Floyd JR | Director | 10,405 | 632,520 | May 25 2010 | |||
| JP MORGAN PARTNERS BHCA LP | 10% Owner | 27,004 | 1,641,573 | May 15 2008 | |||
| JP MORGAN PARTNERS BHCA LP | 10% Owner | 1,058,640 | 64,354,726 | Jul 11 2007 | |||
| JP MORGAN PARTNERS BHCA LP | 10% Owner | 26,383 | 1,603,823 | May 19 2008 | |||
| JP MORGAN PARTNERS BHCA LP | 10% Owner | 0 | 0 | Apr 10 2006 | |||
| JP MORGAN PARTNERS BHCA LP | 10% Owner | 25,052 | 1,522,911 | Jul 29 2008 | |||
| JP MORGAN PARTNERS BHCA LP | 10% Owner | 0 | 0 | May 23 2006 | |||
| JP MORGAN PARTNERS BHCA LP | 10% Owner | 0 | 0 | Jun 17 2005 | |||
| JP MORGAN PARTNERS BHCA LP | 10% Owner | 0 | 0 | Jan 04 2005 | |||
| LIPPMAN MARC E | Director | 140,908 | 8,565,797 | Nov 05 2020 | |||
| LIPPMAN MARC E | Director | 5,000 | 303,950 | Aug 15 2003 | |||
| LIPPMAN MARC E | Director | 8,000 | 486,320 | May 19 2006 | |||
| LIPPMAN MARC E | Director | 124,950 | 7,595,711 | May 20 2014 | |||
| LIU JEAN I | GC/EVP, Leg Affairs | 64,051 | 3,893,660 | May 13 2021 | |||
| LIU JEAN I | EVP, Legal Affairs & GC | 22,400 | 1,361,696 | Dec 03 2014 | |||
| LOVE TED W | Director | 1,799 | 109,361 | Aug 18 2020 | |||
| MCDONALD MICHAEL | Chief Medical Officer | 0 | 0 | Feb 02 2005 | |||
| MCLAUGHLIN JOHN PETER | Director | 39,400 | 2,395,126 | May 24 2016 | |||
| MCLAUGHLIN JOHN PETER | Director | 32,000 | 1,945,280 | May 20 2014 | |||
| Orwin John A | Director | 26,098 | 1,586,497 | May 19 2020 | |||
| Orwin John A | Director | 5,000 | 303,950 | Jan 14 2014 | |||
| POWELL MICHAEL | Director | 647,577 | 39,366,206 | Dec 16 2004 | |||
| Reynolds Thomas C | Chief Medical Officer | 57,601 | 3,501,565 | Jan 29 2013 | |||
| ROMP CHARLES R | EVP, Commercial | 50,077 | 3,044,181 | Dec 03 2020 | |||
| ROSENBERG MORRIS | SVP, Development | 0 | 0 | Feb 01 2006 | |||
| ROSENBERG MORRIS | EVP, Process Sciences | 17,643 | 1,072,518 | Jun 14 2012 | |||
| SEELEY BRUCE J. | EVP, Commerical | 18,861 | 1,146,560 | Aug 24 2011 | |||
| SENTER PETER | Vice President, Chemistry | 68,148 | 4,142,717 | Aug 22 2003 | |||
| Seth Alpna | Director | 10,048 | 610,818 | May 19 2020 | |||
| SIEGALL CLAY B | President and CEO | 718,760 | 43,693,420 | May 07 2021 | |||
| SIEGALL CLAY B | President & CEO | 951,500 | 57,841,685 | Sep 02 2010 | |||
| Simonian Nancy A | Director | 26,098 | 1,586,497 | May 19 2020 | |||
| Simonian Nancy A | Director | 7,000 | 425,530 | May 20 2014 | |||
| SIMPSON TODD E | Chief Financial Officer | 152,436 | 9,266,584 | Dec 18 2020 | |||
| SIMPSON TODD E | Chief Financial Officer | 168,699 | 10,255,212 | Aug 27 2014 | |||
| SING AMY | Sr. Director Medical Affairs | 72,107 | 4,383,385 | Aug 05 2003 | |||
| SING AMY | Sr. Director Medical Affairs | 52,107 | 3,167,585 | Aug 18 2003 | |||
| SOUTHERN DOUGLAS | Director | 0 | 0 | May 19 2006 | |||
| TAYLOR ROBIN G | Chief Commercial Officer | 33,025 | 2,007,590 | Dec 23 2019 | |||
| TrailSmith Pamela A | Chief Scientific Officer | 6,940 | 421,883 | May 18 2007 | |||
| WELCH DANIEL G | Director | 65,348 | 3,972,505 | Nov 04 2020 | |||
| WELCH DANIEL G | Director | 13,119 | 797,504 | May 20 2014 | |||
| WILLIAMS DOUGLAS E | CSO, EVP R&D | 0 | 0 | Feb 19 2004 |